In addition, to evade the activation of feedback loops, the combination of dual inhibitors against PI3K and mTOR (reviewed in [134]), as well as the simultaneous inhibition of the MAPK together with PI3K/mTOR signaling pathways [135], have shown efficacy in selected tumor types. Here, MTOR is linked to neoplasm.